Clinical Trials
Renal Cell Cancer


A Phase1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors (Bladder, Colon, Gastric, Renal).


A Phase 3 Randomized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy.


A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing CB-839 in Combination with Cabozantinib (CB-Cabo) vs.Placebo with Cabozantinib (Pbo-Cabo) in Patients with Advanced orMetastatic Renal Cell Carcinoma (RCC)